179 related articles for article (PubMed ID: 38533643)
1. Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial.
Berg-Hansen K; Gopalasingam N; Christensen KH; Ladefoged B; Andersen MJ; Poulsen SH; Borlaug BA; Nielsen R; Møller N; Wiggers H
Circulation; 2024 May; 149(19):1474-1489. PubMed ID: 38533643
[TBL] [Abstract][Full Text] [Related]
2. Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock: A Randomized, Controlled, Double-Blind Trial.
Berg-Hansen K; Christensen KH; Gopalasingam N; Nielsen R; Eiskjær H; Møller N; Birkelund T; Christensen S; Wiggers H
JACC Heart Fail; 2023 Oct; 11(10):1337-1347. PubMed ID: 37452805
[TBL] [Abstract][Full Text] [Related]
3. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
4. Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Koepp KE; Melenovsky V
J Am Coll Cardiol; 2015 Oct; 66(15):1672-82. PubMed ID: 26449137
[TBL] [Abstract][Full Text] [Related]
5. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.
Pieske B; Wachter R; Shah SJ; Baldridge A; Szeczoedy P; Ibram G; Shi V; Zhao Z; Cowie MR;
JAMA; 2021 Nov; 326(19):1919-1929. PubMed ID: 34783839
[TBL] [Abstract][Full Text] [Related]
7. The β-Adrenergic Agonist Albuterol Improves Pulmonary Vascular Reserve in Heart Failure With Preserved Ejection Fraction.
Reddy YNV; Obokata M; Koepp KE; Egbe AC; Wiley B; Borlaug BA
Circ Res; 2019 Jan; 124(2):306-314. PubMed ID: 30582447
[TBL] [Abstract][Full Text] [Related]
8. Exercise Stress Real-Time Cardiac Magnetic Resonance Imaging for Noninvasive Characterization of Heart Failure With Preserved Ejection Fraction: The HFpEF-Stress Trial.
Backhaus SJ; Lange T; George EF; Hellenkamp K; Gertz RJ; Billing M; Wachter R; Steinmetz M; Kutty S; Raaz U; Lotz J; Friede T; Uecker M; Hasenfuß G; Seidler T; Schuster A
Circulation; 2021 Apr; 143(15):1484-1498. PubMed ID: 33472397
[TBL] [Abstract][Full Text] [Related]
9. Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Borlaug BA; Melenovsky V; Koepp KE
Circ Res; 2016 Sep; 119(7):880-6. PubMed ID: 27458234
[TBL] [Abstract][Full Text] [Related]
10. Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction: The METEORIC-HF Randomized Clinical Trial.
Lewis GD; Voors AA; Cohen-Solal A; Metra M; Whellan DJ; Ezekowitz JA; Böhm M; Teerlink JR; Docherty KF; Lopes RD; Divanji PH; Heitner SB; Kupfer S; Malik FI; Meng L; Wohltman A; Felker GM
JAMA; 2022 Jul; 328(3):259-269. PubMed ID: 35852527
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
Borlaug BA; Reddy YNV; Braun A; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Carter R
Circulation; 2023 Sep; 148(10):834-844. PubMed ID: 37534453
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION Trial.
Hundertmark MJ; Adler A; Antoniades C; Coleman R; Griffin JL; Holman RR; Lamlum H; Lee J; Massey D; Miller JJJJ; Milton JE; Monga S; Mózes FE; Nazeer A; Raman B; Rider O; Rodgers CT; Valkovič L; Wicks E; Mahmod M; Neubauer S
Circulation; 2023 May; 147(22):1654-1669. PubMed ID: 37070436
[TBL] [Abstract][Full Text] [Related]
13. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
15. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Edelmann F; Wachter R; Schmidt AG; Kraigher-Krainer E; Colantonio C; Kamke W; Duvinage A; Stahrenberg R; Durstewitz K; Löffler M; Düngen HD; Tschöpe C; Herrmann-Lingen C; Halle M; Hasenfuss G; Gelbrich G; Pieske B;
JAMA; 2013 Feb; 309(8):781-91. PubMed ID: 23443441
[TBL] [Abstract][Full Text] [Related]
16. One-Year Committed Exercise Training Reverses Abnormal Left Ventricular Myocardial Stiffness in Patients With Stage B Heart Failure With Preserved Ejection Fraction.
Hieda M; Sarma S; Hearon CM; MacNamara JP; Dias KA; Samels M; Palmer D; Livingston S; Morris M; Levine BD
Circulation; 2021 Sep; 144(12):934-946. PubMed ID: 34543068
[TBL] [Abstract][Full Text] [Related]
17. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
[TBL] [Abstract][Full Text] [Related]
18. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial.
Nassif ME; Windsor SL; Tang F; Khariton Y; Husain M; Inzucchi SE; McGuire DK; Pitt B; Scirica BM; Austin B; Drazner MH; Fong MW; Givertz MM; Gordon RA; Jermyn R; Katz SD; Lamba S; Lanfear DE; LaRue SJ; Lindenfeld J; Malone M; Margulies K; Mentz RJ; Mutharasan RK; Pursley M; Umpierrez G; Kosiborod M
Circulation; 2019 Oct; 140(18):1463-1476. PubMed ID: 31524498
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.
Malhotra R; Dhakal BP; Eisman AS; Pappagianopoulos PP; Dress A; Weiner RB; Baggish AL; Semigran MJ; Lewis GD
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27301469
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary Capillary Wedge Pressure Patterns During Exercise Predict Exercise Capacity and Incident Heart Failure.
Eisman AS; Shah RV; Dhakal BP; Pappagianopoulos PP; Wooster L; Bailey C; Cunningham TF; Hardin KM; Baggish AL; Ho JE; Malhotra R; Lewis GD
Circ Heart Fail; 2018 May; 11(5):e004750. PubMed ID: 29695381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
